What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Retina
Ophthalmology, Retinitis pigmentosa, Macular degeneration, Eye disease and Fundus are his primary areas of study.
Many of his studies involve connections with topics such as Choroid and Ophthalmology.
The various areas that Alan C. Bird examines in his Retinitis pigmentosa study include Dystrophy and Electroretinography.
His study in the field of Drusen is also linked to topics like Monozygotic twin.
Alan C. Bird has researched Eye disease in several fields, including Retinopathy, Prospective cohort study and Confidence interval.
His work deals with themes such as Retinitis pigmentosa GTPase regulator and Pathology, which intersect with Fundus.
His most cited work include:
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin - 1-year results of a randomized clinical trial - VIP report no. 1 (490 citations)
- X-linked retinitis pigmentosa. (229 citations)
- Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. (221 citations)
What are the main themes of his work throughout his whole career to date?
Alan C. Bird focuses on Ophthalmology, Macular degeneration, Retinal, Retinitis pigmentosa and Pathology.
His Ophthalmology study frequently draws parallels with other fields, such as Retinopathy.
His Macular degeneration research focuses on Retinal pigment epithelium and how it relates to Anatomy.
His Retinal study combines topics from a wide range of disciplines, such as Retina and Internal medicine.
His studies in Retinitis pigmentosa integrate themes in fields like Retinal degeneration, Dystrophy, Genetic heterogeneity and Electroretinography.
Alan C. Bird usually deals with Fluorescein angiography and limits it to topics linked to Fundus and Optometry.
He most often published in these fields:
- Ophthalmology (53.30%)
- Macular degeneration (24.93%)
- Retinal (20.06%)
What were the highlights of his more recent work (between 2009-2021)?
- Ophthalmology (53.30%)
- Macular telangiectasia (14.33%)
- Macular degeneration (24.93%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Ophthalmology, Macular telangiectasia, Macular degeneration, Visual acuity and Retinal.
Alan C. Bird interconnects Optometry and Retina in the investigation of issues within Ophthalmology.
In his work, Dermatology is strongly intertwined with Pathology, which is a subfield of Retina.
His work carried out in the field of Macular telangiectasia brings together such families of science as Microperimetry, Fundus and Disease.
Alan C. Bird combines subjects such as Autoantibody, Age related and Atrophy with his study of Macular degeneration.
His research in Visual acuity intersects with topics in Electroretinography, Photopic vision, Natural history and Healthy ageing, Ageing.
Between 2009 and 2021, his most popular works were:
- Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future (157 citations)
- Geographic Atrophy: A Histopathological Assessment (101 citations)
- Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2. (96 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Retina
Alan C. Bird mainly investigates Ophthalmology, Macular degeneration, Macular telangiectasia, Visual acuity and Retina.
Alan C. Bird combines topics linked to Healthy subjects with his work on Ophthalmology.
His Macular degeneration research integrates issues from Retinal pigment epithelium, Rotterdam Study and Pathology.
The study incorporates disciplines such as Choroid and Anatomy in addition to Retinal pigment epithelium.
His Visual acuity research is multidisciplinary, incorporating perspectives in Optical coherence tomography, Electroretinography, Optometry, Consecutive case series and Retinitis pigmentosa.
Retina and Retinal are frequently intertwined in his study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
